-
EP3458095
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3458095
| EP3458095 - VARIANT PD-L1 POLYPEPTIDES, T-CELL MODULATORY MULTIMERIC POLYPEPTIDES, AND METHODS OF USE THEREOF [Right-click to bookmark this link] | Status | Grant of patent is intended Status updated on 07.05.2024 Database last updated on 15.06.2024 | |
| Former | Examination is in progress Status updated on 27.08.2020 | ||
| Former | Request for examination was made Status updated on 22.02.2019 | ||
| Former | The international publication has been made Status updated on 25.11.2017 | Most recent event Tooltip | 07.05.2024 | New entry: Communication of intention to grant a patent | Applicant(s) | For all designated states Albert Einstein College of Medicine 1300 Morris Park Avenue Bronx, NY 10461 / US | [2019/38] |
| Former [2019/13] | For all designated states Albert Einstein College of Medicine, Inc. 1300 Morris Park Avenue Bronx, NY 10461 / US | Inventor(s) | 01 /
GARRETT-THOMSON, Sarah, C. 116 Seaman Avenue Apt. 2A New York, NY 10034 / US | 02 /
ALMO, Steven, C. 850 James Street Pelham, NY 10803 / US | 03 /
SEIDEL, Ronald, D. 726 Larchmont Acres Apt. C Larchmont, NY 10538 / US | [2019/13] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [N/P] |
| Former [2019/13] | Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | Application number, filing date | 17800069.1 | 17.05.2017 | [2019/13] | WO2017US33042 | Priority number, date | US201662338128P | 18.05.2016 Original published format: US 201662338128 P | [2019/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017201131 | Date: | 23.11.2017 | Language: | EN | [2017/47] | Type: | A1 Application with search report | No.: | EP3458095 | Date: | 27.03.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.11.2017 takes the place of the publication of the European patent application. | [2019/13] | Search report(s) | International search report - published on: | US | 23.11.2017 | (Supplementary) European search report - dispatched on: | EP | 25.10.2019 | Classification | IPC: | A61K39/395, C07K14/705, C07K16/28 | [2019/13] | CPC: |
C07K14/70532 (EP,IL,KR,US);
A61K39/395 (IL);
C07K14/70521 (EP,IL,KR,US);
A61K35/17 (KR);
A61K9/0019 (US);
A61P19/02 (EP);
A61P25/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP,KR);
C07K14/70539 (KR,US);
C07K16/28 (IL);
C12N15/62 (KR);
C12N5/0636 (KR);
A61K38/00 (KR);
C07K2319/00 (KR);
C07K2319/02 (KR);
C07K2319/20 (KR,US);
C07K2319/30 (EP,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/13] | Title | German: | VARIANTE PD-L1-POLYPEPTIDE, T-ZELL-MODULIERENDE MULTIMERE POLYPEPTIDE UND VERFAHREN ZUR VERWENDUNG DAVON | [2019/13] | English: | VARIANT PD-L1 POLYPEPTIDES, T-CELL MODULATORY MULTIMERIC POLYPEPTIDES, AND METHODS OF USE THEREOF | [2019/13] | French: | VARIANTS DE POLYPEPTIDES PD-L1, POLYPEPTIDES MULTIMÈRES MODULATEURS DES LYMPHOCYTES T ET PROCÉDÉS D'UTILISATION CORRESPONDANTS | [2019/13] | Entry into regional phase | 14.11.2018 | National basic fee paid | 14.11.2018 | Search fee paid | 14.11.2018 | Designation fee(s) paid | 14.11.2018 | Examination fee paid | Examination procedure | deleted | Date on which the examining division has become responsible | 14.11.2018 | Examination requested [2019/13] | 19.05.2020 | Amendment by applicant (claims and/or description) | 26.08.2020 | Despatch of a communication from the examining division (Time limit: M04) | 06.01.2021 | Reply to a communication from the examining division | 21.05.2021 | Despatch of a communication from the examining division (Time limit: M06) | 29.11.2021 | Reply to a communication from the examining division | 06.02.2023 | Despatch of a communication from the examining division (Time limit: M06) | 10.08.2023 | Reply to a communication from the examining division | 08.05.2024 | Communication of intention to grant the patent | Fees paid | Renewal fee | 15.05.2019 | Renewal fee patent year 03 | 14.05.2020 | Renewal fee patent year 04 | 13.05.2021 | Renewal fee patent year 05 | 16.03.2022 | Renewal fee patent year 06 | 14.03.2023 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [AP]WO2017059819 (GUANGZHOU INST BIOMED & HEALTH [CN]) [AP] 22,23 * abstract ** sequences 8-19, 21-24, 26-29 * | International search | [A]US2013017199 (LANGERMANN SOLOMON [US]) [A] 1-2, 3/1-2, 7-15, 16/7-15, 17/16/7-15, 27/7-14, 28/7-14 * ; paragraphs [0078]-[0080], [0085], [0093] *; | [A]WO2015195531 (EINSTEIN COLL MED [US]) [A] 7-15, 16/7-15, 17/16/7-15, 27/7-14, 28/7-14* ; paragraphs [0033]-[0034], [0049]; figures 19F, 26A *; | [A]WO2016000619 (KANG YANSHEN [CN], et al) [A] 1-2, 3/1-2, 7-15, 16/7-15, 17/16/7-15, 27/7-14, 28/7-14 * ; paragraphs [0112], [0149], [0156], [0159] *; | [A]US2016011204 (ALMO STEVEN C [US], et al) [A] 1-2, 3/1-2, 7-15, 16/7-15, 17/16/7-15, 27/7-14, 28/7-14 * ; figures 12, 18; paragraphs [0031], [0038] * | by applicant | US4235871 | US4501728 | US4837028 | WO9303769 | WO9309239 | WO9319191 | WO9412649 | WO9428938 | WO9500655 | WO9511984 | US6287860 | US7078387 | WO2007103515 | WO2009023270 | US2009092582 | US2010189682 | WO2010091122 | - ALTSCHUL et al., J. Mol. Bioi., (19900000), vol. 215, pages 403 - 10 | - BROMLEY et al., Annu Rev Immunol., (20010000), vol. 19, pages 375 - 96 | - SCHERAGA, Rev. Computational Chem., (19920000), pages 11173 - 142 | - KRISHNAMURTHY et al., J. Immunol., (20080000), vol. 180, page 4458 | - HAN et al., J. Clin. Invest., (20050000), vol. 115, page 1879 | - JARCHUM et al., Clin. Immunol., (20080000), vol. 127, page 359 | - SKOWERA et al., J. Clin. Invest., (20080000), vol. 118, page 3390 | - HASSOUNEH et al., Methods Enzymol., (20120000), vol. 502, page 215 | - Philos Trans R Soc Lond B Biol Sci., (20020000), vol. 357, page 165 | - MEGEED et al., Adv Drug Deliv Rev., (20020000), vol. 54, page 1075 | - SCHELLENBERGER et al., Nat Biotechnol., (20090000), vol. 27, page 1186 | - LI et al., Invest Opthalmol Vis Sci, (19940000), vol. 35, page 2543 2549 | - BORRAS et al., Gene Ther, (19990000), vol. 6, page 515 524 | - LIDAVIDSON, PNAS, (19950000), vol. 92, page 7700 7704 | - SAKAMOTO et al., H Gene Ther, (19990000), vol. 5, page 1097 | - ALI et al., Hum Gene Ther, (19980000), vol. 9, page 81 86 | - FLANNERY et al., PNAS, (19970000), vol. 94, no. 10319, page 6916 6921 | - BENNETT et al., Invest Opthalmol Vis Sci, (19970000), vol. 38, page 2857 2863 | - JOMARY et al., Gene Ther, (19970000), vol. 4, page 683 690 | - ROLLING et al., Hum Gene Ther, (19990000), vol. 10, page 641 648 | - ALI et al., Hum Mol Genet, (19960000), vol. 5, page 591 594 | - SAMULSKI et al., J. Vir., (19890000), vol. 63, pages 3822 - 3828 | - MENDELSON et al., Virol., (19880000), vol. 166, pages 154 - 165 | - FLOTTE et al., PNAS, (19930000), vol. 90, pages 10613 - 10617 | - TAKAHASHI et al., J Virol, (19990000), vol. 73, page 7812 7816 | - BITTER et al., Methods in Enzymology, (19870000), vol. 153, pages 516 - 544 | - SZOKA et al., Ann. Rev. Biophys. Bioeng., (19800000), vol. 9, page 467 |